论文信息 - P16 HEALTH-RELATED QUALITY OF LIFE FOR FRAIL TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DARATUMUMAB, LENALIDOMIDE AND DEXAMETHASONE: SUBGROUP ANALYSIS OF MAIA TRIAL - 字舞流文

P16 HEALTH-RELATED QUALITY OF LIFE FOR FRAIL TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DARATUMUMAB, LENALIDOMIDE AND DEXAMETHASONE: SUBGROUP ANALYSIS OF MAIA TRIAL

T. Plesner | H. Nahi | T. Facon | A. Chari | K. Gries | B. Arnulf | M. Roussel | L. Karlin | C. Hulin | K. Weisel | R. Carson | P. Mollee | H. Pei | S. Kaila | A. Jaccard | N. Gupta | K. Ramasamy | M. Delforge | S. Usmani | N. Bahlis | F. Borgsten | S. Kumar | A. Perrot | R. Orlowski | K. Matt